Learn more about how MidAtlantic Permanente Medical Group (MAPMG) used Breast IHC AI deployed in HALO AP® to standardize prognostic scores in newly diagnosed breast cancers and increase diagnostic efficiency of first reads.
HALO AP® and Breast IHC AI at MAPMG Read More »
Discover how Guardant Health has seamlessly integrated Lunit SCOPE PD-L1 with HALO AP® for enhanced PD-L1 analysis.
Adam Smith shares his journey from being a HALO® customer to helping lead Indica Labs’ mission of making AI accessible to pathologists everywhere.
People of Pathology Podcast: Adam Smith – Making AI Accessible For All With Indica Labs Read More »
9 December 2025 | Indica Labs is pleased to announce our London HALO® User Group Meeting at Hilton London Metropole on 9 December from 12:00 – 16:00 Lunch will be provided to all pre-registered attendees.
Indica Labs’ London HALO® User Group Meeting 2025 Read More »
With 45 pathologists and over half a million whole slide images (WSIs) produced annually, this network of London trusts deploys Aperio GT 450 DX scanners
21 October 2025 | Indica Labs is pleased to announce our Bay Area HALO® User Group Meeting at The Lighthouse Café & Conference Center on 21 October from 10:00am – 3:30pm. Lunch will be provided to all pre-registered attendees at 12:20pm.
Indica Labs’ Bay Area HALO® User Group Meeting 2025 Read More »
Download this Application Note to learn more about how Lunit SCOPE PD-L1 was integrated into the HALO AP® digital pathology solution at Guardant Health.
Lunit SCOPE PD-L1 and HALO AP® Application Note Read More »
Learn more about the automated workflow and benefits of utilizing Lung PD-L1 AI.
Lung PD-L1 AI Brochure Read More »
Learn more about Indica Labs’ novel CE-IVD certified deep learning clinical workflow for prostate cancer grading.
Novel CE-IVD clinical workflow for analysis of prostate cancer core needle biopsies Read More »
